• Products
    • VitaSmart™ Hypothermic Oxygenated Perfusion System
    • Belzer UW® Cold Storage Solution
    • Belzer MPS® UW Machine Perfusion Solution
    • EasiSlush® Sodium Chloride Solution
    • Cannulas for Organ Perfusion
    • International Availability
  • About
    • About Bridge to Life Ltd.
    • Company Leadership
    • News & Press Releases
    • Events
    • Scientific Advisory Board
    • Bridge to HOPE
    • Webinars
  • Clinical Resource Library
  • Contact & Support
    • Contact Us
    • Customer Feedback Form
    • Coordinated Vulnerability Disclosure Process
Trusted Solutions. Advanced Technology. Uncompromising Quality.
  • Products
    • VitaSmart™ Hypothermic Oxygenated Perfusion System
    • Belzer UW® Cold Storage Solution
    • Belzer MPS® UW Machine Perfusion Solution
    • EasiSlush® Sodium Chloride Solution
    • Cannulas for Organ Perfusion
    • International Availability
  • About
    • About Bridge to Life Ltd.
    • Company Leadership
    • News & Press Releases
    • Events
    • Scientific Advisory Board
    • Bridge to HOPE
    • Webinars
  • Clinical Resource Library
  • Contact & Support
    • Contact Us
    • Customer Feedback Form
    • Coordinated Vulnerability Disclosure Process

randomized-controlled trial

randomized-controlled trial
Machine perfusion techniques for liver transplantation- A meta-analysis of the first seven randomized-controlled trials

Machine perfusion techniques for liver transplantation- A meta-analysis of the first seven randomized-controlled trials

This meta-analysis, comprising 1,017 patients across seven RCTs, demonstrates that both HOPE and NMP significantly reduce early allograft dysfunction (EAD) rates compared to SCS. HOPE was [...]

Read More

Latest Posts

UK NICE Issues Guidance Recommending Routine NHS Funding for Bridge to Life’s VitaSmart™ Hypothermic Oxygenated Perfusion System

UK NICE Issues Guidance Recommending Routine NHS Funding for Bridge to Life’s VitaSmart™ Hypothermic Oxygenated Perfusion System

August 27, 2026

DULUTH, GA, & LONDON, UK - August 27, 2026 - Bridge to Life™ Ltd., a global leader in organ preservation solutions and perfusion technologies, today highlighted the recent release of […]

Read more
Bridge to Life Raises $110 Million to Make Hypothermic Oxygenated Perfusion the Standard of Care in Liver Transplantation and Beyond

Bridge to Life Raises $110 Million to Make Hypothermic Oxygenated Perfusion the Standard of Care in Liver Transplantation and Beyond

August 12, 2026

Financing will further accelerate the already successful early commercial rollout of VitaSmart™ HOPE System Company also advancing an active organ viability assessment tool designed to raise industry standards with a […]

Read more
New Investigator Initiated Research Data Demonstrate Efficacy and Safety of the Bridge to Life’s VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) System in Multiple Organ Transplants

New Investigator Initiated Research Data Demonstrate Efficacy and Safety of the Bridge to Life’s VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) System in Multiple Organ Transplants

June 23, 2026

Studies in human uterus and small intestine transplants, including head-to-head comparison with normothermic oxygenated perfusion, presented at 2026 Annual Meeting of the American Transplant Congress (ATC) in Boston Duluth, GA […]

Read more




full

info@b2ll.com

US Operations:
3300 Breckinridge Blvd. Suite 200 | Duluth, GA 30096 USA

© 2026 Bridge to Life™ Ltd. All rights reserved.

EVENTS



Sep

15

September 15 – September 16


National Critical Issues Forum



Sep

16

September 16 – September 17


XIII International Course on HPB surgery



Sep

16

September 16 – September 18


SFPC


View Calendar


EXPLORE BTL

Products

Contact & Support

About

Recent News

Privacy Policy

Social Responsibility

Certifications

JOIN OUR EMAIL LIST

SOCIAL MEDIA

Linkedin

X

VitaSmart™ is available in Europe, Saudi Arabia, India, and in all countries accepting the CE mark. VitaSmart™ Hypothermic Oxygenated Perfusion System is authorized to be sold in the US market, pending regulatory approval in all other countries.

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search